SIR, Measurement of serum creatine kinase is an accepted procedure in the follow up of patients with polymyositis or dermatomyositis. This parameter is nearly always raised at some point in the illness, and serves as a useful guide in making decisions regarding therapy. There are preliminary reports on the importance of determination of serum myoglobin levels in such patients, however, suggesting that changes of myoglobin levels may precede alterations of creatine kinase and clinical features.' Since the assay for measuring myoglobin is time consuming and expensive and requires the use of radioactive isotopes, it was of interest to perform a prospective study dealing with the possible differences of myoglobin and creatine kinase levels in patients with polymyositis or dermatomyositis and their relevance to the clinical situation.
Eight patients (one male, seven female) entered this study and were followed up for a mean period of 80 weeks (range 23-121 weeks). Five of them had definite polymyositis group I, the others definite dermatomyositis group One hundred and five sera were screened for creatine kinase and myoglobin. Fig. 1 shows the positive correlation between these parameters. Obviously, this correlation is of significance (r=0-948, p<0-001). It appeared that by using the myoglobin assay no additional-clinically relevantinformation could be obtained since myoglobin and creatine kinase levels correlated equally well with muscle strength and function. In only two cases was an increase of myoglobin concentration found one week before an increase in creatine kinase was observed. Owing to the longitudinal character of this study, however, it could be that this was only incidental and of no importance with respect to the clinical features and therapy. This conflicts with preliminary data from other investigators which indicated that increases in myoglobin levels may precede changes in creatine kinase by several weeks or months and thus could be applied as a useful guide for therapy.' Clearly, myoglobin is a more specific indicator of muscle damage than creatine kinase since it is found and synthesised exclusively in skeletal and heart muscle cells3; in contrast, creatine kinase derived from non-muscle tissue has been described.4 The present study, however, does not confirm the advantage of monitoring myoglobin rather than creatine kinase in patients with polymyositis or dermatomyositis. One of the reasons that myoglobin-in spite of its higher muscle specificity-is not a better parameter than creatine kinase in the follow up of such patients is that myoglobin is eliminated very quickly from the blood by renal excretion. Muscle damage due to excessive exercise leads to a rise in myoglobin concentrations within 30 minutes, but the levels return to normal within several hours after exercise.5 Therefore, myoglobin is probably a very sensitive parameter for monitoring acute muscle damage. In patients with polymyositis or dermatomyositis, however, in whom chronic muscle damage 
